Nava Health Expands Southern Footprint: First Center in North Carolina Brings Personalized, Root-Cause Healthcare to Charlotte
COLUMBIA, MD / ACCESSWIRE / March 11, 2024 / Nava Health, a leader in integrative and functional medicine, expands its...
Month: March 2024
Clarity Clinic Introduces New PHP/IOP Service Line at Chicago Loop Location
Clarity Clinic's PHP/IOP Program is designed to provide intensive and structured support for individuals experiencing significant mental health symptoms, specifically...
RETRANSMISSION: Redeye Initiates Coverage of PMD Device Solutions
STOCKHOLM, SWEDEN / ACCESSWIRE / March 11, 2024 / PMD Device Solutions (STO:PMDS) Redeye assigns a base-case valuation of SEK...
Skye Bioscience Announces $40 Million Private Placement Equity Financing
Financing expected to fund strategic expansion of obesity clinical development and extend operating runway beyond 2026San Diego, California--(Newsfile Corp. -...
Userful Revolutionizes Healthcare with First-of-its-Kind Data Dashboards for Mission-Critical Operations
SAN RAMON, Calif.--(BUSINESS WIRE)--Userful Corporation™, a leading provider of IT solutions for core enterprise operations, unveils its groundbreaking data dashboards...
Milu Health Announces $4.8M Seed Round Led by a16z Bio + Health and Partners with Employers to Expand Employee Access to AI-driven Health Savings Platform
The company’s platform identifies where patients can save money on health costs by finding fairly priced doctors, accessing affordable medications,...
Accuhealth Elevates Remote Care With Introduction of Service-Level Agreements for Enhanced Patient Response
Accuhealth's Commitment to Excellence: New SLAs to Set Higher Standards for Patient Care and OutcomesMCALLEN, TX / ACCESSWIRE / March...
Kayne Anderson Growth Capital Invests in TeleMed2U, a Multi-Specialty Telehealth Platform
ROSEVILLE, CA / ACCESSWIRE / March 11, 2024 / TeleMed2U, a leading provider of telemedicine solutions, is excited to announce...
Global Health Intelligence Shares Insights on Medical Equipment Market Leaders in Latin America
GHI provides key insights into Latin America's medical equipment sales leadersMIAMI, FL / ACCESSWIRE / March 11, 2024 / Global...
FSD Pharma Submits a Phase-1b Clinical Trial Application for Ethics Committee for its Proprietary Beverage unbuzzd(TM)
TORONTO, ON / ACCESSWIRE / March 11, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical...
Sonnet BioTherapeutics Announces Early Safety Data from the Company’s Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Met the Study’s Initial Pre-Specified Objective
Safety in the Phase 1b part of Sonnet's double-blind, randomized, controlled trial of SON‑080 was reviewed by the study's Data...
Whittier Street Health Center to Honor Vertex Pharmaceuticals Executive Chairman Jeffrey Leiden at Its 2024 Annual Gala
Whittier's Annual Roast to Toast Fundraiser on April 3rd, 2024 Will Support Health and Social Services for Boston's Most Vulnerable...
Late-Breaking Presentation at American Academy of Dermatology 2024 Annual Meeting Shows that JNJ-2113, the First and Only Investigational Targeted Oral Peptide, Maintained Skin Clearance in Moderate-To-Severe Plaque Psoriasis Through One Year
Long-term extension (LTE) FRONTIER 2 study demonstrated sustained efficacy and similar safety results from Week 16 to Week 52, consistent...
Nasdaq Accepts NLS Pharmaceutics’ Plan to Regain Listing Compliance
ZURICH, SWITZERLAND / ACCESSWIRE / March 11, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
Scryb Appoints Yoav Raiter, CEO, to its Board of Directors
Toronto, Ontario--(Newsfile Corp. - March 10, 2024) - Scryb Inc. (CSE: SCYB) (OTC Pink: SCYRF) (FSE: EIY) ("Scryb'' or the...
New Research Reveals Genomic Profile of Seborrheic Dermatitis and Answers Key Questions on Immune Response and Skin Barrier Dysfunction
Findings show that seborrheic dermatitis is a unique inflammatory skin disease with its own molecular signatureSuggests skin barrier disruption in...
Alumis Presents Positive Data from Phase 2 Clinical Trial of ESK-001, an Oral Allosteric TYK2 Inhibitor for the Treatment of Plaque Psoriasis, at AAD Annual Meeting
– STRIDE Phase 2 primary endpoint of PASI 75 and key secondary endpoints met at all clinically relevant doses tested;...
Samsung Bioepis Presents Two Abstracts for Its Immunology Portfolio at the 2024 American Academy of Dermatology (AAD) Annual Meeting
Interchangeability study for HADLIMA (adalimumab-bwwd) was conducted in accordance with the FDA’s Guidance for Industry; primary pharmacokinetics (PK) endpoints as...
Ultimovacs ASA: Mandatory notification of trades by primary insider
Oslo, 9 March 2024: Langøya Invest AS, a closely related party of Ketil Fjerdingen, a board member and primary insider...
Aesthetic Medical International Holdings Group Ltd. Announces Receipt of a Letter of Expected Delisting Determination From Nasdaq Staff and Intention to Request a Hearing before the Nasdaq Hearings Panel
SHENZHEN, China, March 08, 2024 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”),...